An Intrinsic Calculation For InnoCare Pharma Limited (HKG:9969) Suggests It's 49% Undervalued

Simply Wall StMar 17 01:10 ET

GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.

GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.

Zhitong FinanceMar 16 21:18 ET

InnoCare Pharma Schedules Board Meeting for Annual Results Approval

TipRanksMar 14 05:45 ET

INNOCARE (09969.HK) plans to hold a Board of Directors meeting on March 27 to approve the annual performance.

Gelonghui, March 14丨INNOCARE (09969.HK) announced that the Board of Directors will hold a meeting on March 27, 2025 (Thursday) to consider and approve the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and its release.

Gelonghui FinanceMar 14 05:22 ET

INNOCARE: DATE OF BOARD MEETING

HKEXMar 14 05:05 ET · Announcements

Trending Industry Today: WUXI BIO Leads Gains In Biotechnology Stocks

Moomoo NewsMar 13 23:30 ET